Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
A new risk score could help clinicians differentiate viral meningitis from community-acquired bacterial meningitis (CABM), according to a review article by Rodrigo Hasbun, MD, MPH, at UTHealth Houston.
A translational research study from collaborating UTHealth Houston laboratories of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, on the new mechanism mediating the anti-diabetic effects of incretins has been published in Cell Reports Medicine.
A five-year, nearly $3.5 million grant to study the mechanisms of brain receptors involved in neurological disorders such as learning disabilities has been awarded to Vasanthi Jayaraman, PhD, of UTHealth Houston by the National Institutes of Health.
Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.
